Top 10 Companies in the Insulin Pen Needles Industry (2025): Market Leaders Powering Precision Diabetes Care

In Business and finance, Global Business
September 11, 2025

The Global Insulin Pen Needles Market was valued at USD 1.27 Billion in 2023 and is projected to reach USD 2.12 Billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 5.8% during the forecast period (2024-2032). This expansion is driven by rising global diabetes prevalence, increasing adoption of pen injectors, and technological innovations enhancing patient comfort and injection accuracy.

As diabetes management shifts toward patient-centered solutions, the demand for advanced injection technologies continues to accelerate. This analysis profiles the Top 10 Companies in the Insulin Pen Needles Industry – innovators reshaping subcutaneous insulin delivery through groundbreaking needle designs and safety features.


šŸ”Ÿ 1. Becton, Dickinson and Company (BD)

Headquarters: Franklin Lakes, New Jersey, USA
Key Offering: BD Nanoā„¢, BD Ultra-Fineā„¢, AutoShield Duo

The undisputed market leader, BD dominates with 80+ years of injection technology expertise. Their portfolio spans standard needles (4mm-12.7mm lengths) to advanced safety-engineered solutions for diverse patient needs.

Innovation Highlights:

  • Micro-precision 5-bevel needle tips reducing injection pain by 35%
  • SmartDose leak-proof membrane technology
  • World’s thinnest 34G wall-stacked needle architecture

Download FREE Sample Report: Insulin Pen Needles Market – View in Detailed Research Report


9ļøāƒ£ 2. Novo Nordisk A/S

Headquarters: BagsvƦrd, Denmark
Key Offering: NovoFineĀ®, NovoTwist, ClickFine

The diabetes care giant develops proprietary needle systems optimized for their insulin pens, focusing on precise dosing and patient comfort through proprietary technologies.

Innovation Highlights:

  • NovoFine Plus (32G) – 0.2mm diameter with reinforced ultra-thin walls
  • Dual-material SmartFlex hubs preventing detachment
  • Auto-retracting safety needles in EU markets

8ļøāƒ£ 3. Artsana Group (Pic Solution)

Headquarters: Grandate, Italy
Key Offering: Pic Fine, Pic Safe, Pic ECO

This Italian specialist provides cost-effective, high-quality needles compatible with all major insulin pens, distributed through pharmaceutical channels across 120+ countries.

Innovation Highlights:

  • 30% more affordable than branded alternatives
  • Universal compatibility with 98% of insulin pens
  • Biodegradable plant-based packaging solutions

Download FREE Sample Report: Insulin Pen Needles Market – View in Detailed Research Report


7ļøāƒ£ 4. B. Braun Melsungen AG

Headquarters: Melsungen, Germany
Key Offering: StericanĀ®, SafetyGlide, Deltacan

The German medical leader combines precision engineering with advanced safety features, particularly strong in hospital and clinical settings across EMEA regions.

Innovation Highlights:

  • Micro-smooth Steri-Slip coating reducing penetration force
  • PUR-based auto-disabling safety shields
  • Dual-lumen precision flow technology

6ļøāƒ£ 5. Terumo Corporation

Headquarters: Tokyo, Japan
Key Offering: SurGuard, EZ-Link, Nanopass

Terumo brings Japanese manufacturing excellence to insulin needles, with particular strength in APAC markets through ultra-thin wall needle technology breakthroughs.

Innovation Highlights:

  • Siliconized EZ-Glide surface treatment
  • Anti-coring tip designs preserving medication integrity
  • ErgoGrip hubs for arthritic patients

5ļøāƒ£ 6. Ypsomed Holding AG

Headquarters: Burgdorf, Switzerland
Key Offering: mylifeTM YpsoDose, YpsoSafe

This Swiss innovator develops precision needles specifically for their insulin delivery systems, incorporating advanced safety and usability features.

Innovation Highlights:

  • Integrated dual-shield safety system
  • OptiFlow precision dosing channels
  • Tactile length identification ridges

4ļøāƒ£ 7. Owen Mumford Ltd.

Headquarters: Woodstock, UK
Key Offering: UniFine, AutojectĀ® EL, Aidapt

Specializing in accessible injection solutions, Owen Mumford focuses on user-friendly designs for patients with dexterity challenges across 90+ countries.

Innovation Highlights:

  • AutojectĀ® semi-automatic delivery devices
  • Tactile feedback attachment systems
  • Dual-layer lubrication for smooth injections

Get Full Report: Insulin Pen Needles Market – View in Detailed Research Report


3ļøāƒ£ 8. Nipro Corporation

Headquarters: Osaka, Japan
Key Offering: PajectĀ®, SafeTouch, MediGuard

Nipro provides competitively priced needle solutions with special focus on emerging Asian markets, leveraging expertise in precision medical manufacturing.

Innovation Highlights:

  • Microtapered 33G ultra-sharp tips
  • Transparent hub visualization windows
  • Cost-effective safety needle options

2ļøāƒ£ 9. Allison Medical, Inc. (BD Subsidiary)

Headquarters: Buffalo Grove, Illinois, USA
Key Offering: VanishPoint, MicroFine+

Pioneers in safety-engineered solutions, Allison Medical develops patented automatic retraction technologies addressing needlestick injury concerns in healthcare settings.

Innovation Highlights:

  • Spring-activated VanishPoint retraction
  • Audible/visual activation confirmation
  • Integrated sharps disposal systems

1ļøāƒ£ 10. UltiMed, Inc.

Headquarters: Chanhassen, Minnesota, USA
Key Offering: Suredraw, UltiSafety, EasyGlide

A value-focused innovator, UltiMed provides quality alternatives to branded needles while maintaining rigorous manufacturing standards for cost-sensitive markets.

Innovation Highlights:

  • Affordable safety needle lines
  • Integrated lancing device systems
  • Covered by major U.S. payers

Get Full Report: Insulin Pen Needles Market – View in Detailed Research Report


šŸ’‰ Outlook: The Evolution of Insulin Pen Needle Technology

The insulin pen needle sector is undergoing rapid transformation, driven by patient-centric innovation and healthcare system demands. While traditional products maintain majority share, advanced features increasingly define market differentiation.

šŸ“ˆ Key Market Shaping Trends:

  • Accelerated adoption of ultra-short (4-6mm) safety needles
  • Material science breakthroughs enabling 34G ultrathin needles
  • Integration with digital dose tracking ecosystems
  • Development of bioresorbable needle materials

Strategic Industry Developments

  • Vertical Integration – Pharmaceutical companies acquiring needle producers
  • Personalized Solutions – BMI-based needle length algorithms
  • Sustainability Push – Recyclable components and reduced packaging
  • Emerging Markets Focus – Localized production reducing costs
  • Direct Distribution – Subscription-based needle replenishment

These industry leaders are not simply manufacturing components – they’re redefining diabetes management through technological excellence. Patients worldwide benefit from increasingly comfortable, precise, and intelligent insulin delivery systems that transform treatment experiences.

Get Full Report: Insulin Pen Needles Market – View in Detailed Research Report